Schrodinger raises $232M in IPO
Drug discovery software company Schrödinger raised $232 million in its IPO, which closed Monday. The company’s stock was trading at $27.22 on Tuesday.
AI drug discovery company Recursion Pharmaceuticals raises $121M Series C
Recursion's technology works by generating millions of cellular images and using AI-based software as a way to analyze the data set and screen potential therapeutic compounds against a variety of diseased cells.
presented by
The Top-Rated Orthopedic Surgery Centers in the Houston Area and Beyond
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.